Calixarene-entrapped nanoemulsion for uranium extraction from contaminated solutions

Journal of Pharmaceutical Sciences

Volumn 99, Issue 3, 2010, Pages 1375-1383

  Spagnul, Aurélie ^a,b,c   Bouvier Capely, Céline ^c   Phan, Guillaume ^c   Rebière, François ^c   Fattal, Elias ^a,b  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b CNRS   (France)

^c INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE IRSN   (France)

Author keywords

Calixarene; Chelating agent; Nanoemulsion; Uranium

Indexed keywords

CALIXARENE; POLYCYCLIC AROMATIC HYDROCARBON DERIVATIVE; TRICARBOXYLATE CALIX [6]ARENE; UNCLASSIFIED DRUG; URANIUM;

AQUEOUS SOLUTION; ARTICLE; CONTAMINATION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; EXTRACTION; NANOEMULSION; PH; PHYSICAL CHEMISTRY; SKIN DECONTAMINATION; SOLUBILITY; ZETA POTENTIAL;

EID: 76649144160     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.21932     Document Type: Article

References (30)

1. Gerber GB, Thomas RG. 1992. Internal radionuclide contamination guidebook. Radiat Prot Dosim 41:1-49.
2. De Rey BM, Lanfranchi HE, Cabrini RL. 1983. Percutaneous absorption of uranium compounds. Environ Res 30:480-491.
3. Petitot F, Moreels AM, Paquet F. 2004. In vitro evaluation of percutaneous diffusion of uranyl nitrate through intact or excoriated skin of rat and pig. Can J Physiol Pharmacol 82:133-139.
4. Petitot F, Gautier C, Moreels AM, Frelon S, Paquet F. 2007. Percutaneous penetration of uranium in rats after a contamination on intact or wounded skin. Radiat Prot Dosim 127:125-130.
5. Petitot F, Frelon S, Moreels AM, Claraz M, Delissen O, Tourlonias E, Dhieux B, Maubert C, Paquet F. 2007. Incorporation and distribution of uranium in rats after a contamination on intact or wounded skin. Health Phys 92:464-474.
6. Lopez R, Diaz Sylvester PL, Ubios AM, Cabrini RL. 2000. Percutaneous toxicity of uranyl nitrate: Its effect in terms of exposure area and time. Health Phys 78:434-437.
7. Fukuda S. 2005. Chelating agents used for plutonium and uranium removal in radiation emergency medicine. Curr Med Chem 12:2765-2770.
8. Bailey BR, Eckerman KF, Townsend LW. 2003. An analysis of a puncture wound case with medical intervention. Radiat Prot Dosim 105:509-512.
9. Taylor DM, Taylor SK. 1997. Environmental uranium and human health. Rev Environ Health 12:147-157.
10. Houpert P, Muller D, Chazel V, Claraz M, Paquet F. 2003. Effect of DTPA on the nephrotoxicity induced by uranium in the rat. Radiat Prot Dosim 105:517-520.
11. Durbin PW. 2008. Lauriston S. Taylor Lecture: The quest for therapeutic actinide chelators. Health Phys 95:465-492.
12. Pavlakis N, Pollock CA, McLean G, Bartrop R. 1996. Deliberate overdose of uranium: Toxicity and treatment. Nephron 72:313-317.
13. Houpert P, Chazel V, Paquet F. 2004. A local approach to reduce industrial uranium wound contamination in rats. Can J Physiol Pharmacol 82:73-78.
14. Yang Z, Xu K, Wang L, Gu H, Wei H, Zhang M, Xu B. 2005. Self-assembly of small molecules affords multifunctional supramolecular hydrogels for topically treating simulated uranium wounds. Chem Commun 4414-4416.
15. Xu K, Ge W, Liang G, Wang L, Yang Z, Wang Q, Hsing IM, Xu B. 2008. Bisphosphonate-containing supramolecular hydrogels for topical decorporation of uranium-contaminated wounds in mice. Int J Radiat Biol 84:353-362.
16. Boulet B, Bouvier-Capely C, Cossonnet C, Cote G. 2006. Solvent extraction of U(VI) by calix[6]arenes. Solvent Extract Ion Exch 24:319-330.
17. Leroux JC. 2007. Injectable nanocarriers for biodetoxification. Nat Nanotechnol 2:679-684.
18. Dhanikula AB, Khalid NM, Lee SD, Yeung R, Risovic V, Wasan KM, Leroux JC. 2007. Long circulating lipid nanocapsules for drug detoxification. Biomaterials 28:1248-1257.
19. Phan G, Le Gall B, Grillon G, Rouit E, Fouillit M, Benech H, Fattal E, Deverre JR. 2006. Enhanced decorporation of plutonium by DTPA encapsulated in small PEG-coated liposomes. Biochimie 88:1843-1849.
20. Duval R, Cossonnet C, Bouvier-Capely C, Le Strat C, Boulet B. 2006. Chelator, French Patent, FR 2006/001105.
21. Liu W, Sun D, Li C, Liu Q, Xu J. 2006. Formation and stability of paraffin oil-in-water nano-emulsions prepared by the emulsion inversion point method. J Colloid Interface Sci 303:557-563.
22. Rowe RC, Sheskey PJ, Weller PJ. 2003. Handbook of pharmaceutical Excipients. Fourth ed. London: Pharmaceutical Press and American Pharmaceutical Association.
23. Ghadially R, Halkier-Sorensen L, Elias PM. 1992. Effects of petrolatum on stratum corneum structure and function. J Am Acad Dermatol 26:387-396.
24. Stamatas GN, de Sterke J, Hauser M, von Stetten O, van der Pol A. 2008. Lipid uptake and skin occlusion following topical application of oils on adult and infant skin. J Dermatol Sci 50:135-142.
25. Lo Nostro P, Casnati A, Bossoletti L, Dei L, Baglioni P. 1996. Complexation properties of calixarenes in Langmuir films at the water-air interface. Colloids Surf A: Physicochem Eng Aspects 116:203-209.
26. Lo Nostro P, Capuzzi G, Fratini E, Dei L, Baglioni P. 2001. Modulation of interfacial properties of functionalized calixarenes. Progress in Colloid and Polymer Science 118:238-242.
27. Dei L, Casnati A, Lo Nostro P, Baglioni P. 1995. Selective complexation by p-tert-butylcalix[6]arene in monolayers at the water-air interface. Langmuir 11:1268-1272.
28. Capek I. 2004. Degradation of kinetically-stable o/w emulsions. Adv Colloid Interf Sci 107:125-155.
29. Guo L, Warnken KW, Santschi PH. 2007. Retention behavior of dissolved uranium during ultrafiltration: Implications for colloidal U in surface waters. Mar Chem 107:156-166.
30. Boulet B. 2006. Selective extraction by calixarens: Application to radiotoxicology. Ph.D. dissertation, ed. University of Paris VI.